The SoftBank-backed Fourier Intelligence Appoints Dr. Arno Stienen as the Group’s Scientific Advisor

Dr. Stienen, an internationally renowned scientist, and educator will provide his consultancy to support Fourier, the industry leader in new product development

Dr. Arno Stienen
Group’s Scientific Advisor
Fourier Intelligence

SINGAPORE, April 25, 2022 – The agreement between Fourier and Dr. Stienen was made official on April 1, 2022. Dr. Stienen will be Fourier Intelligence Group’s scientific advisor, responsible for consultancy in new product development, technology transfer, product commercialisation, OEM projects identification, joint labs, and strategic alliance partners collaboration.

Dr. Stienen specialises in human-machine interaction, exoskeletons, and robotics in unstructured and compliant environments. He has a proven track record of cross-functional iterative collaborations to resolve complex problems and has the demonstrated ability to develop and commercialise robotics solutions. Dr. Stienen has previously initiated and led dozens of projects and teams of various professionals.

Zen Koh, Co-founder and Group Deputy CEO of Fourier Intelligence, expresses his delight to have Dr. Stienen on board with Fourier. “Arno has been an old friend, and we have collaborated successfully in the past. With his stellar experience in exoskeleton and robotics applications, we believe he will play an instrumental role in Fourier’s future innovation and product development.”

“I am excited to take on this role as the official scientific advisor of Fourier Intelligence”, said Dr. Arno Stienen. “I look forward to utilising my experience across all phases from product development to strategic partners collaboration,” Dr. Stienen added.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Zen KOH Appears On The Front Cover of NR Times Issue 21

Zen Koh, Co-Founder and Global HQ CEO, Fourier Intelligence Group

SINGAPORE, March 29th, 2022 – Zen KOH, Co-founder & Deputy Group CEO of Fourier Intelligence was recently featured on the front cover of NRTimes magazine as he discusses how Fourier Intelligence is poised to lead the expansion of the ever-burgeoning rehab tech sector globally.

To read more about the magazine, click here.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.

The award-winning Canadian MyndMove™ therapy from MyndTec. Inc joins SoftBank-backed rehab robotics leader Fourier Intelligence’s network of partners

SINGAPORE, March 23rd, 2022 – Fourier Intelligence has announced a strategic alliance partnership with MyndTec Inc, an award-winning Canadian medical technology company specialising in innovative therapeutic medical devices.

This partnership will focus on the distribution of MyndMove™, a non-invasive functional electrical stimulation-based intervention, to the ever-expanding global network of Fourier Intelligence.

A virtual signing ceremony was held to commemorate the partnership between both parties. MyndTec’s CEO, Craig Leon, Co-Founder, Dr Milos R. Popovic, Fourier Intelligence Co-Founder and Global HQ CEO, Zen Koh, General Manager, Owen Teoh and Operations Director, Sandra Lee, attended the virtual event.

From top left: Mr Owen Teoh, General Manager, Fourier Intelligence, Dr Milos R. Popovic, Co-Founder MyndTec Inc., and Ms Sandra Lee, Operations Director, Fourier Intelligence.
From bottom left: Mr Craig Leon, CEO of MyndTec Inc. and Mr Zen Koh, Fourier Intelligence Global HQ CEO

This partnership is timely as both parties recently reached strategic milestones. Fourier Intelligence received a Series D growth investment led by the SoftBank Group and backed by the Saudi Aramco P7 Venture Fund and the Yuanjing Capital earlier this year. MyndTec met all the requirements of the Canadian Securities Exchange (CSE) and began trading its common shares on the CSE on February 24th under the ticker symbol MYTC.

“Our partnership with MyndTec Inc. signifies yet another successful strategic collaboration with market leaders to offer innovative and clinically effective technology for our patients globally,” said Zen Koh, Co-Founder and Global HQ CEO of Fourier Intelligence. “MyndMove™, an electrical stimulation-based intervention, integrates perfectly into Fourier’s RehabHub™ solution and complement our existing product/technology portfolio. Fourier will continue our investment into more of such joint technological developments to better provide highly integrated intelligent rehabilitation technologies to empower clinicians and patients.”

Fourier’s global network spans over 50 countries to ensure a broad market outreach for innovative technologies. With joint laboratories with some of the top research institutes in the world such as ETH Zürich, University of Melbourne, and Shirley Ryan AbilityLab in Chicago, Fourier is set to chart the new frontier of innovative medical technologies.

MyndMove™ therapy
RehabHubTM

“We are excited to enter into this meaningful partnership with Fourier Intelligence to strategically integrate our MyndMove™ technology into RehabHub™. Fourier’s proven track record establishing globally successful RehabHub™, positively changing patient lives globally and the addition of MyndTec’s innovative MyndMove™ therapy to this network will enable us to reach out to more patients worldwide,” said Craig Leon, CEO of MyndTec.

MyndTec’s medical devices are designed to improve function, maximise independence, and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or some cases of traumatic brain injury*.

MyndTec Inc. also partners with several organisations such as the KITE Research Institute, the research arm of the Toronto Rehabilitation Institute – University Health Network and the University of Toronto to develop and commercialise MyndMove™ therapy. The MyndMove™ therapy is also supported by numerous clinical studies, including randomised controlled trials in stroke and spinal cord injuries. The embedded stimulation protocols in MyndMove™ allows clinicians to stimulate natural, purposeful, and functional movements in patients.

*Disclaimer: MyndMove™ claims may differ depending on the jurisdiction. Please contact MyndTec for details.

Media Contact
MyndTec Inc.
Craig Leon
Email:  investor.relations@myndtec.com
(416) 569-0430

Fourier Intelligence
Grace NG
Senior Marketing Manager
Email: marketing.globalhq@fftai.com

Fourier Intelligence Closed RMB 400 Million in Series D Funding from SoftBank Vision Fund 2

The new funding will accelerate market expansion, enable innovation across its advanced healthcare robotics solutions and accelerate global growth opportunities

SINGAPORE, January 26, 2022 – Fourier Intelligence, a Shanghai-based medical technology company, received a growth investment of RMB 400 million in Series D Funding, led by SoftBank Vision Fund 2 and backed by Saudi Aramco P7 Venture Fund and the Yuanjing Vision Plus Capital. The new funding will accelerate Fourier’s go-to-market expansion, enable innovation across its advanced healthcare robotics solutions and accelerate global growth opportunities.

Led by Alex Gu, Founder and Group CEO, and Zen Koh, Co-Founder and Group Deputy CEO, Fourier Intelligence is a global leader in Neurorehabilitation Robotics, Artificial Intelligence (AI) and digital rehabilitation solutions for the healthcare industry. Leveraging intelligent robotics, smart actuators, sensors, machine learning, and proprietary control algorithms, Fourier develops and provides an intelligent healthcare robotic platform, RehabHub™, that delivers tailored digital healthcare solutions that revolutionise the neurorehabilitation industry. The company has 1,000+ global institutional healthcare customers and 17 international research joint labs in Singapore, Chicago, Phoenix, Zürich, Melbourne, Madrid, Kobe, and Kuala Lumpur.

Fourier focused on delivering widespread patient access to technology-enabled therapies. We achieve this with our intelligent robotic solution, RehabHub™, which is effective and affordable.

— Zen Koh, Co-founder & Group Deputy CEO

 “The rehabilitation market has significant tech adoption potential, and we grew our revenue close to over 3 times in 2021, despite the challenges posed by the global pandemic.”, said Alex Gu, Founder and Group CEO of Fourier Intelligence. “China sees increasing demand for rehabilitation services with the ageing population, increased number of patients with chronic diseases, and rehab development in the clinics. There has been a continuous shortage of physicians nationwide. In addition, Fourier’s comprehensive product portfolio with solid capabilities in hardware (including force sensor, monitor, and controller) and algorithm (for force control and feedback) is well-positioned to address clinical pain points. We believe intelligent rehabilitation technology companies like Fourier Intelligence can solve the talent bottleneck and provide practical and quantifiable treatments to improve patient outcomes. We are pleased to partner with Joanne Xu and the SoftBank Investment Advisers team to continue our development of the intelligent rehabilitation sector. We look forward to harnessing their support to create significant value not only for the medical rehabilitation robotic communities but also for the robotic world to tackle the most complex global challenges facing humanity and the environment.”

As a global leading manufacturer and solutions provider of AI-powered rehabilitation robotics, Fourier is committed to technological innovation and has been leading, supporting, and participating in international scientific research in the field of rehabilitation robotics. Some of such initiatives are joint research laboratories, respectively, with the Shirley Ryan AbilityLab (formerly known as the Rehabilitation Institute of Chicago) in the United States, the University of Melbourne in Australia, ETH Zürich in Switzerland, National University of Singapore, Kobe University in Japan and the KITE Research Institute at the Toronto Rehabilitation Institute in Canada. These partnerships put Fourier at the forefront of technological innovation and enable Fourier to offer industry-leading products across end-to-end rehabilitation services, with innovative solutions to solve specific clinical constraints.

Influential Colossal Investment Institution Backs Unicorn-to-be Neurorehabilitation Robotic Company in Defining the Future of the Industry

“As China’s population ages, there is increasing demand for rehabilitation services, but these patients face a shortage of qualified therapists,” said Joanne Xu, Partner at SoftBank Investment Advisers. “We believe that Fourier Intelligence is well placed to solve this talent bottleneck by using technology to provide effective and quantifiable treatments to achieve better patient outcomes. It has built an integrated solution combining a digital platform, hospital services and a comprehensive product portfolio in collaboration with 30+ world-leading hospitals and research institutions. We are excited to partner with Alex Gu and the team to support technological innovation in China’s rehabilitation sector.”

Driven by its vision of ‘rehabilitation for all’ through intelligent technology, Fourier Intelligence implemented a series of modern rehabilitation centres with strategic institutional clinical partners under its RehabHub™ concept. The possibility of data interconnectivity and multi-machine coordination between multiple rehabilitation robotics reduced the number of clinicians required, significantly improving efficiency and costs. The company aims to become a global one-stop solution provider for intelligent rehabilitation whilst providing world-class technology that is affordable and highly competitive for the clinical market.

“Our mission as a company is to enable widespread patient access to life-changing technology-enabled therapies. One of the biggest obstacles to achieving this is the high costs and low technology adoption rate. Our team focused on the urgent need to enhance availability, accessibility, and affordability, yet ensuring the effectiveness of our intelligent robotic solution, RehabHub™,” added Zen Koh. “The significant experience and capital that our strategic investors bring to Fourier will help us rapidly realise global commercialisation and to deliver these innovative therapies to as many patients as quickly as possible.”

“Prosperity 7 is thrilled to continue supporting Fourier in this latest round of investment and through ongoing strategic collaboration,” said Aysar Tayeb, Executive Managing Director of P7. “We hope to land Fourier’s rehabilitation solutions within the Kingdom’s network of hospitals and clinics and look forward to working with the company to deliver the most advanced rehabilitation services and solutions and improve recovery and the quality of life for patients in Saudi Arabia and beyond.”


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhub@fftai.com

Fourier Intelligence Joins the IFR

IFR

Rehabilitation robotics pioneers, Fourier Intelligence, formally accepted as members of the International Federation of Robotics (IFR)

SINGAPORE, Jan 20, 2022Fourier Intelligence has been formally accepted as a member of the International Federation of Robotics (IFR), joining a group of well-acclaimed institutional members from the robotics industry and research and development institutes such as KUKA, Intel and Panasonic. Fourier Intelligence will also be the pioneering member to represent rehabilitation robotics in the IFR.

The IFR’s mission is to connect the world of robotics around the globe, with the aim of promoting the positive benefits of robotics for productivity, competitiveness, economic growth, and quality of work and life. This non-profit organisation also serves the purpose to promote research, development, use and international co-operation in the entire field of robotics.

“We are happy and very much looking forward to being part of the IFR,” said Zen Koh, Co-Founder and Global HQ CEO of Fourier Intelligence. “Being a member of this federation is a great privilege. This will allow us to have a platform to share information on the latest technology trends and exchange ideas with other top members in this. We are also excited to foster more alliances and partnerships with other members which we believe will be very beneficial to our company’s growth.”

Co-Founder and Global HQ CEO of Fourier Intelligence, Zen Koh

“Besides that, the vision of the federation also aligns perfectly with Fourier’s vision, which is to promote the positive benefits of robotics in various fields such as rehabilitation. As a pioneering member to represent rehabilitation robotics, we are very excited to advocate the adoption of robotics in rehabilitation worldwide.”

The IFR also works closely with the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organisation for electronic and electrical engineering. Since 2005, together with the IEEE, both has been co-sponsoring the IEEE/IFR Innovation and Entrepreneurship Award. The purpose of this award is to recognise the entrepreneurial commercialisation of ideas into actual products. The IFR and IEEE also jointly sponsors the IERA (Innovation and Entrepreneurship in Robotics and Automation) Award, which is to honor achievements of investors who propel value creating ideas into world-class products. Both the IFR and IEEE have a huge influence in the robotics industry.

Upon being accepted as a member of the IFR, Fourier Intelligence has plans to work closely together to release more white papers on rehabilitation robotics. Fourier Intelligence believes that together with the vast network of over 75 members of IFR from more than 20 countries, the awareness and adoption of rehab robotics can be more widely promoted globally.


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: grace.ng@fftai.com

Barrow Neurological Institute MoU

Barrow Neurological Institute and Fourier Intelligence Renew Partnership

Barrow Neurological Institute MoU

Barrow Neurological Institute and Fourier Intelligence to continue their collaboration in advancing rehabilitation technology

ARIZONA, January 10, 2022 In light of their initial Memorandum of Understanding (MoU) that was signed in 2019, Barrow Neurological Institute and Fourier Intelligence have decided to continue their collaboration in advancing rehabilitation technology through signing a new MoU.

The signing ceremony was held virtually on the 10th of January 2022 to commemorate the collaboration between both parties. The MoU signing ceremony was led by Trent Maruyama, Program Manager for Rehabilitation Technology of Barrow Neurological Institute and Zen Koh, Co-Founder and Global Hub CEO of Fourier Intelligence. Also present to witness the virtual signing ceremony were Fourier Intelligence’s General Manager, Mr Owen Teoh, Senior Manager for Clinical Application and Research, Ms Sarah Lim, Clinical Consultants for Oceania and North America, Ms Taya Hamilton and Ms Daniela Mattos.

This MoU renewal will further strengthen the current cooperation and relationship between both parties to continue working closely together in this and other future research. “This MoU builds on an already strong relationship with Barrow Neurological Institute,” said Zen Koh. “We look forward to continue providing them with our assistance in their research through our intelligent robotic rehabilitation devices as well as other additional support.”

Zen Koh also mentioned that he believes that the similar ambitions between Fourier Intelligence and Barrow Neurological Institute contributes to the success of this collaboration. “Both Fourier and Barrow Neurological Institute care greatly about rehabilitation and aspire to advance rehabilitation technology. We have been working closely with them since 2019 and we have seen tremendous progress in the clinical application area. We are truly grateful for this understanding.”

Trent Maruyama also gave his comments when asked about his thoughts and opinions of signing the MoU. “We have had nothing but very positive results throughout the previous collaboration and I am very excited to achieve more in the upcoming years to further advance the science and technology in rehabilitation.”, said Trent.

“The main thing we are trying to achieve from this new collaboration is to push the limitation of rehabilitation robotics. Combining Fourier’s science and engineering capabilities with the clinical skillset from Barrow Neurological Institute, we believe that it is the perfect match to push the boundaries in bringing rehabilitation robotics to the next level.”, added Trent.

Barrow Neurological Institute, the world’s largest neurological research institution and one of the best neurosurgical training centres in the United States, are currently conducting research with Arizona State University to evaluate the efficacy of robotics and conventional therapy in the rehabilitation of acute stroke patients using a couple of Fourier Intelligence’s ArmMotus™ M2 Gen.


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: grace.ng@fftai.com

Fourier Intelligence Shares Knowledge and Technology to the World

Co-Founder and Global Hub CEO, Zen Koh, discusses about Fourier Intelligence’s influence and success to the world

SINGAPORE, Dec 23, 2021 – With the expansion of Fourier Intelligence continuing at pace globally, and its rehabilitation robotics being used increasingly around the world, its international presence has never been stronger. Zen Koh, Co-Founder and Global Hub CEO of Fourier Intelligence talks about Fourier’s collaboration with University of Melbourne, led by world-renowned figure in robotics, Professor Denny Oetomo.

Its partnership with University of Melbourne, finalised in 2019, proves to be a key component in its international expansion. Through the creation of the Robotics Laboratory, a joint initiative between the University of Melbourne and Fourier, the opportunities for innovation and knowledge transfer between experts are being channelled into increasing rehab provision on an international scale. This can be seen from the result of the development and launch of the ArmMotus™ EMU – Fourier’s latest and next-gen robot, hailed as the “neurorehabilitation redefining technology”.

To read more about this interview, click here


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: grace.ng@fftai.com

innorehab

Innorehab 2021 – Enhancing the Ability of Rehabilitation Services for the Disabled

innorehab

Fourier Intelligence supported the finals of the 5th edition of the Innorehab

SHANGHAI, Dec 11, 2021 – The finals of the 5th edition of the Innorehab was held in Shanghai Zhangjiang Robot Valley, Pudong New Area in Shanghai and was hosted by the Chinese Journal of Rehabilitation Medicine with support from Fourier Intelligence. Team “Grasp the Future with Your Hands” took first place in the competition with their work titled “Multi degree-of-freedom Fine Assisted Hand Rehabilitation Exoskeleton Robot”.

Winners of the Innorehab 2021

The Innorehab has been held for five consecutive years and has become a creative platform for the rehabilitation industry domestically. The competition aims to provide a stage for Chinese rehabilitation workers to showcase their creativity in the rehabilitation field, provide sustainable ways to industrialise their ideas and promote continuous development of China’s rehabilitation medicine. The competition also boosts the development of rehabilitation technology in China to a new level. Compared with previous years, the number of participants has reached a new high, with 45% increment in the “prototype stage” and 34% in the “design stage”.

Panelists for the Innorehab 2021

The top 10 finalists in the Innorehab 2021 covered a wide range of topics and interests in the rehabilitation field such as ideal companions for elderly osteoporosis patients, social assistance robots for children with autism spectrum disorders, pelvis assisted exoskeleton system, and the intelligent closed-loop control cupping device. The intelligent closed-loop control cupping device took the runner-up spot, perfectly showcasing the combination of traditional Chinese medicine with modern technology. The amazing cooperation between a team of engineers and clinical frontliners successfully won the third place with their retractor.

The winning team came from the Institute of Automation of the Chinese Academy of Sciences. Their multi degree-of-freedom fine assisted hand rehabilitation exoskeleton robot fully embodies the innovative power of science and technology. Ao Lijuan, dean of the School Rehabilitation of Kunming Medical University, believes that this work has successfully achieved three degrees of freedom for the thumb with control of three motors.

Wu Yi, Director of Department of Rehabilitation Medicine, Huashan Hospital, Fudan University

Wu Yi, director of the Department of Rehabilitation Medicine at Huashan Hospital affiliated to Fudan University, pointed out that, “In the past 5 years, we have seen an increasing number of rehabilitation workers, students and groups participate in the Innorehab. We have found that the submissions have been more clinical, and the quality of the work has been improving. Some of the ideas and designs even successfully became an actual product.”

Alex Gu Jie, President of Fourier Intelligence Group

Alex Gu Jie, the President of Fourier Intelligence Group, commented that a large number of works have been relatively improved this year. “The submissions have really matured this year. We not only see drawings and sketches now, but we also seen many actual prototypes. This is very exciting for us as it means that people are taking this competition more seriously now.”

General Manager of Fourier Intelligence Global Hub, Owen Teoh, who was watching the live stream of the Innorehab, was very impressed with this year’s top 10 finalists. “This year’s finalists showcased really impressive innovations and ideas. I have previously attended the Innorehab in Shanghai a few years back and it was a great experience. We have since then work on bringing the Innorehab to other countries especially Malaysia, Singapore and Australia, and hopefully we will be successful with that in the near future.”


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: grace.ng@fftai.com

university of malaya

Fourier Supports University of Malaya Medical Centre’s PWD Event

university of malaya

Fourier Intelligence supports University of Malaya Medical Centre’s event in conjunction with International Day of Persons with Disabilities

KUALA LUMPUR, Dec 10, 2021 – Fourier Intelligence supports University of Malaya Medical Centre’s (UMMC) “A Group Exhibition by Artists-Patients”, an event hosted by UMMC in conjunction with the International Day of Persons with Disabilities that will be held from December 4th to 14th 2021 in the Plaza, University Malaya Medical Centre.

This event was an initiative done by the Department of Rehabilitation Medicine of UMMC to showcase their support to people with disabilities. This event also serves to create more awareness to the public regarding to the International Day of Persons with Disabilities that falls on the 3rd of December annually. The International Day of Persons with Disabilities aims to promote the rights and well-being of persons with disabilities (PWDs) in all spheres of societies.

To showcase this support for PWDs, the Department of Rehabilitation Medicine of UMMC organised a group art exhibition for their patients with disabilities to display their artworks. Amazing artworks such as drawing, painting, sketches, batiks, and masks were proudly displayed throughout the Plaza. These artworks were also available for sale to the public with profits returning to the patients themselves.

Prof Dr. Madya Mazlina binti Mazlan, Head of Department of Rehabilitation Medicine, expresses her gratitude to all the attendees and participants during her opening speech. She also reminded everyone on the objective and importance of the event which is to generate more public awareness and support PWDs. The director of UMMC, Professor Dr. Nazirah binti Hasnan, were also in attendance to the opening ceremony of this event which was accompanied by musical performances such as piano and singing by PWDs.

Fourier Intelligence is one of the main sponsors of this event, further emphasizing on their support for PWDs. Tai Zhi Kang, Business Development Director of Fourier Intelligence, also attended the event. “It was remarkable to witness the department of rehabilitation medicine of UMMC carry out such a successful event. It opens one eye to the endless possibilities and abilities of PWDs to create such amazing series of artworks. This event serves as a great platform for PWDs to showcase their talents and abilities as well as to generate public awareness.”

Feel free to show your support for this event in the Plaza, University of Malaya Medical Centre as the admission is free of charge. Exhibition period will be on the weekdays from 9am to 4pm. For more information, visit here


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +65-6911-6651
Email: grace.ng@fftai.com

innorehab 2021

Fourier to Host 5th Edition of Innorehab

innorehab 2021

Fourier Intelligence will be hosting Innorehab, a creative rehabilitation competition, this weekend

SHANGHAI, Nov 7, 2021 – Fourier Intelligence will be hosting the 5th edition of the Innorehab at their headquarters located in Zhangjiang Robot Valley, Pudong New Area on the 11th of December at 1:30pm.

Fourier Intelligence’s HQ, Zhangjiang Robot Valley

Innorehab is an annual competition organised by the Chinese Journal of Rehabilitation Medicine and Fourier Intelligence to provide a platform for first-line rehabilitation therapists and physicians from local hospitals in China, groups or individuals who are keen on research and development of rehabilitation products as well as university professors and students with pursuing rehabilitation majors to brainstorm high-quality rehabilitation methods, solve current rehabilitation problems and promote the development of the rehabilitation industry in various aspects.

Since the opening of the registration on 2nd of July 2021, the preliminary round of Innorehab has received thousands of submissions with re-entry rate of previous contestants exceeding 30%. Approximately half of the submissions come from lecturers and students, who are closely following the trend of medical-industry integration to build more advanced clinical rehabilitation.

The submissions then went through a preliminary review that was led thoroughly by Zhu Yulian, deputy director of the Department of Rehabilitation Medicine of Huashan Hospital & Fudan University, and many other top rehabilitation physicians and rehabilitation therapists to select ten of the best projects for the final round. The review was based on 4 important criteria – practicality, scientifically, readiness, and technology level.

For more information about Innorehab, feel free to scan this QR code.


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +65-6911-6651
Email: grace.ng@fftai.com